Results 101 to 110 of about 126,231 (300)
A Large Parotid Hemangioma Managed Successfully with Propranolol
Fandresena Arilala Sendrasoa, Tsiory Iarintsoa Razafimaharo, Samson Leophonte Ramily, Lala Soavina Ramarozatovo, Fahafahantsoa Rapelanoro Rabenja Department of Dermatology, Faculty of Medicine, University of Antananarivo, Antananarivo, 101 ...
Sendrasoa FA+4 more
doaj
ObjectivesTo evaluate the prognostic value of ultrasound and MRI findings in patients with infantile hemangioma undergoing propranolol therapy.MethodsThis study was based on retrospective interpretation of prospectively acquired data.
Hee Jin Park+3 more
doaj +1 more source
Os hemangiomas infantis são os tumores mais comuns da infância, ocorrendo em cerca de 3 a 10% das crianças com ida- de inferior a um ano de idade, com predomínio no sexo feminino.
Passas, Maria Armanda, Teixeira, Marta
core +1 more source
Clinical analysis of kasabach-merritt syndrome in 17 neonates [PDF]
BACKGROUND: Kasabach-Merritt syndrome (KMS) is characterized by giant hemangiomas and severe thrombocytopenia, which may result in life-threatening multi-organ hemorrhage.
Li Tao+4 more
core +1 more source
Outcomes of a fledgling public dermatology clinic in rural Australia
Abstract There is paucity of research available regarding the epidemiological characteristics of patients attending dermatology outpatient services in rural Australia. We performed a retrospective cohort study of patients attending a public dermatology clinic established at Dubbo Base Hospital in rural New South Wales. The broad range of dermatological
Grace Xiaoying Li+2 more
wiley +1 more source
To study the role of propranolol in infantile hemangioma: A prospective randomized study
Background: Infantile capillary hemangiomas (IHs) are common, benign, self-limited tumors with a well-defined natural history, occurring most often on the head and neck. IHs are the most common soft-tissue tumors in infancy and occur in 5–10% of children.
Pokhariya BMS +2 more
doaj +1 more source
Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma. Despite the clinical benefit of propranolol therapy in hemangioma, the mechanistic understanding of what drives this outcome is limited ...
Jeroen Overman+17 more
doaj +1 more source
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients [PDF]
[Background] Von Hippel-Lindau (VHL) disease is a rare oncological disease with an incidence of 1:36,000, and is characterized by the growth of different types of tumors: hemangioblastomas in the central nervous system (CNS) and retina ...
Albiñana, Virginia+7 more
core +1 more source
Abstract Background Infantile hemangiomas (IH) affect 2%–10% of the pediatric population. The current standard treatment for complicated IH is oral propranolol. Propranolol initiation protocols vary depending on institution and may occur in an inpatient setting for patients <5‐week‐corrected‐age, with a history of premature birth, and or with low ...
Katelyn Rypka+6 more
wiley +1 more source
Sclerotherapy for the treatment of infantile hemangiomas
Sclerotherapy is a simple, technically easy and effective mode of treatment for infantile hemangiomas (IH). It acts by blocking the growth of actively proliferating lesions, by targeting their vascularity accelerating their regression. Polidocanol is a commonly used sclerosant.
Chander Grover+2 more
openaire +3 more sources